NEW OPPORTUNITIES OF MONOTHERAPY WITH NEBILET FOR PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION
Nebilet – is a new β-adrenoceptor blocking agent possessing both superseleсtive and NO-producing properties. Efficacy and safety of nebilet monotherapy of 5 mg/d were evaluated for 20 patients with mild and moderate essential hypertension during 8 weeks of treatment. Positive hypotensive effect was...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2000-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2240 |